Amplification and attenuation of lung metastases depending on glucocorticoid dosage implicating long‐acting activated memory cells induced by nivolumab against malignant melanoma
Abstract Firstly, glucocorticoids such as prednisolone can attenuate the effect of anti–PD‐1 antibody nivolumab. Secondly, malignant melanoma cells survived latently and unnoticeably in places other than those of previous metastatic lesions. Thirdly, effector T cells activated by nivolumab sustained...
Main Authors: | Katsunori Katagiri, Kiyoto Shiga, Daisuke Saito, Shin‐ichi Oikawa, Aya Ikeda, Kodai Tsuchida, Jun Miyaguchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2349 |
Similar Items
-
Severe Pneumonitis after Nivolumab Treatment Accompanied by Acute Pulmonary Embolism in a Patient with Lung Adenocarcinoma
by: Ji-Ping Liao, et al.
Published: (2017-01-01) -
Case Report. Extracorporeal Membrane Oxygenation in Nivolumab Associated Pneumonitis
by: Schneider Thomas-Michael, et al.
Published: (2017-04-01) -
A clinical case of immune-mediated pneumonitis after nivolumab in a patient with Burkitt lymphoma
by: K. I. Utesheva, et al.
Published: (2023-03-01) -
The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
by: Takeshi Fukumoto, et al.
Published: (2022-08-01) -
The Role of Radiology in Progressive Fibrosing Interstitial Lung Disease
by: Ahmad Abu Qubo, et al.
Published: (2022-01-01)